Oral contraceptives modify DNA methylation and monocyte-derived macrophage function

Biology of Sex Differences

Volumn 3, Issue 1, 2012, Pages

  Campesi, Ilaria ^a,b   Sanna, Manuela ^a,b   Zinellu, Angelo ^b,c   Carru, Ciriaco ^a,b   Rubattu, Laura ^d   Bulzomi, Pamela ^e   Seghieri, Giuseppe ^f   Tonolo, Giancarlo ^g   Palermo, Mario ^h   Rosano, Giuseppe ⁱ   Marino, Maria ^e   Franconi, Flavia ^a,b  

^a NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c Porto Conte Ricerche Srl   (Italy)

^d SS Annunziata Hospital   (Italy)

^e ROMA TRE UNIVERSITY   (Italy)

^f Spedali Riuniti ^*  (Italy)

^g San Giovanni di Dio Hospital   (Italy)

^h UNIVERSITY HOSPITAL OF SASSARI   (Italy)

ⁱ IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

androgenic and non androgenic progestin; combined oral contraceptive; estrogen receptors; global DNA methylation; monocyte derived macrophages; TNF

Indexed keywords

ALKALINE PHOSPHATASE; ANDROGEN RECEPTOR; BILIRUBIN; C REACTIVE PROTEIN; CALCIUM; CHLORMADINONE; CHOLESTEROL; CYSTEINE; DESOGESTREL; DROSPIRENONE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FOLLITROPIN; GAMMA GLUTAMYLTRANSFERASE; GESTAGEN; GESTODENE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; HYDROCORTISONE; IRON; LEVONORGESTREL; LIPOPOLYSACCHARIDE; LUTEINIZING HORMONE; N(G),N(G) DIMETHYLARGININE; ORAL CONTRACEPTIVE AGENT; TESTOSTERONE; TRANSFERRIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA METHYLATION; DRUG USE; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HUMAN CELL; IRON BINDING CAPACITY; IRON BLOOD LEVEL; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MACROPHAGE; MACROPHAGE FUNCTION; MONOCYTE DERIVED MACROPHAGE; NORMAL HUMAN; OXYGEN SATURATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTHROMBIN TIME; SIDE EFFECT;

EID: 84991408407     PISSN: 20426410     EISSN: 20426410     Source Type: Journal    
DOI: 10.1186/2042-6410-3-4     Document Type: Article

References (52)

1. Investigational New Drug Applications and New Drug Applications. Rules and Regulations. Federal Register. US Food and Drug Administration, Gender-Specific Medicine FR 6854 Rockville, MD, US FDA 1998 63
2. Contraceptive requirements for clinical research. Cain J, Lowell J, Thorndyke L, Localio AR, Obstet Gynecol 2000 95 861 866 10.1016/S0029-7844(00) 00824-3 10905922
3. Gender differences in drug responses. Franconi F, Brunelleschi S, Steardo L, Cuomo V, Pharmacol Res 2007 55 81 95 10.1016/j.phrs.2006.11.001 17129734 (Pubitemid 46186037)
4. Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Ascenzi P, Bocedi A, Marino M, Mol Aspects Med 2006 27 299 402 10.1016/j.mam.2006.07.001 16914190 (Pubitemid 44255847)
5. Greater inhibition of the pituitary - ovarian axis in oral contraceptive regimens with a shortened hormone-free interval. Willis SA, Kuehl TJ, Spiekerman AM, Sulak PJ, Contraception 2006 74 100 103 10.1016/j.contraception.2006.02.006 16860046 (Pubitemid 44062466)
6. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH, Psychosom Med 1999 61 154 162 10204967 (Pubitemid 29168644)
7. Oral contraception and insulin sensitivity in vivo assessment in normal women and women with previous gestational diabetes. Skouby SO, Andersen O, Saurbrey N, Kuhl C, J Clin Endocrinol Metab 1987 64 519 523 10.1210/jcem-64-3- 519 3102539 (Pubitemid 17020918)
8. Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives. Petersen KR, Christiansen E, Madsbad S, Skouby SO, Andersen LF, Jespersen J, Contraception 1999 60 337 344 10.1016/S0010-7824(99) 00107-9 10715368 (Pubitemid 30133222)
9. Progestogen therapies: differences in clinical effects? Wiegratz I, Kuhl H, Trends Endocrinol Metab 2004 15 277 285 10.1016/j.tem.2004.06.006 15358281 (Pubitemid 39044202)
10. Use of combined oral contraceptives alters metabolic determinants and genetic regulation of C-reactive protein. The Cardiovascular Risk in Young Finns Study. Haarala A, Eklund C, Pessi T, Lehtimaki T, Huupponen R, Jula A, Viikari J, Raitakari O, Hurme M, Scand J Clin Lab Invest 2009 69 168 174 10.1080/00365510802449642 18937150
11. ADMA concentration changes across the menstrual cycle and during oral contraceptive use: the Cardiovascular Risk in Young Finns Study. Valtonen P, Punnonen K, Saarelainen H, Heiskanen N, Raitakari OT, Juonala M, Viikari JS, Alfthan G, Kahonen M, Laaksonen R, Lyyra-Laitinen T, Laitinen T, Heinonen S, Eur J Endocrinol 2010 162 259 265 10.1530/EJE-09-0658 19934267
12. The biochemistry, measurement and current clinical significance of asymmetric dimethylarginine. Blackwell S, Ann Clin Biochem 47 17 28
13. Oral contraceptives and venous thromboembolism: findings in a large prospective study. Vessey M, Mant D, Smith A, Yeates D, Br Med J (Clin Res Ed) 1986 292 526 10.1136/bmj.292.6519.526 (Pubitemid 16126103)
14. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. Spitzer WO, Lewis MA, Heinemann LA, Thorogood M, MacRae KD, BMJ 1996 312 83 88 10.1136/bmj.312.7023.83 8555935
15. Femoral plaques confound the association of circulating oxidized low-density lipoprotein with carotid atherosclerosis in a general population aged 35 to 55 years: the Asklepios Study. Langlois MR, Rietzschel ER, De Buyzere ML, De Bacquer D, Bekaert S, Blaton V, De Backer GG, Gillebert TC, Arterioscler Thromb Vasc Biol 2008 28 1563 1568 10.1161/ATVBAHA.108.167346 18511698
16. Contraceptive hormone use and cardiovascular disease. Shufelt CL, Bairey Merz CN, J Am Coll Cardiol 2009 53 221 231 10.1016/j.jacc.2008.09.042 19147038
17. Atherogenesis during low level hypercholesterolemia in the nonhuman primate. I. Fatty streak formation. Masuda J, Ross R, Arteriosclerosis 1990 10 164 177 10.1161/01.ATV.10.2.164 2180394 (Pubitemid 20103578)
18. Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death. Parihar A, Eubank TD, Doseff AI, J Innate Immun 2 204 215
19. Monocyte and macrophage heterogeneity. Gordon S, Taylor PR, Nat Rev Immunol 2005 5 953 964 10.1038/nri1733 16322748 (Pubitemid 41746764)
20. Estradiol regulates expression of estrogen receptor ERalpha46 in human macrophages. Murphy AJ, Guyre PM, Wira CR, Pioli PA, PLoS One 2009 4 5539 10.1371/journal.pone.0005539 19440537
21. Update on oral contraceptive pills. Cerel-Suhl SL, Yeager BF, Am Fam Physician 1999 60 2073 2084 10569509
22. Sweetman S, Martindale: The Complete Drug Reference London, UK: Pharmaceutical Press 34 2005
23. Variations in serum iron and total iron binding capacity with the time of intake of combined oral contraceptives. Kamyab S, Kamyab SD, Clin Chim Acta 1976 66 439 452 10.1016/0009-8981(76)90244-8 1248147
24. The influence of oral contraceptives on the time-integral of thrombin generation (thrombin potential). Rotteveel RC, Roozendaal KJ, Eijsman L, Hemker HC, Thromb Haemost 1993 70 959 962 8165618 (Pubitemid 24008807)
25. Effect of injectable and oral contraceptives on serum lipids. Berenson AB, Rahman M, Wilkinson G, Obstet Gynecol 2009 114 786 794 10.1097/AOG. 0b013e3181b76bea 19888036
26. Different effects of oral contraceptives containing levonorgestrel or desogestrel on plasma lipoproteins and coagulation factor VII. van Rooijen M, von Schoultz B, Silveira A, Hamsten A, Bremme K, Am J Obstet Gynecol 2002 186 44 48 10.1067/mob.2002.119179 11810082 (Pubitemid 34093737)
27. Is taurine beneficial in reducing risk factors for diabetes mellitus? Franconi F, Di Leo MA, Bennardini F, Ghirlanda G, Neurochem Res 2004 29 143 150 14992273 (Pubitemid 38181708)
28. Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signaling. Acconcia F, Totta P, Ogawa S, Cardillo I, Inoue S, Leone S, Trentalance A, Muramatsu M, Marino M, J Cell Physiol 2005 203 193 201 10.1002/jcp.20219 15389627 (Pubitemid 40330938)
29. 17beta-Estradiol regulates the first steps of skeletal muscle cell differentiation via ER-alpha-mediated signals. Galluzzo P, Rastelli C, Bulzomi P, Acconcia F, Pallottini V, Marino M, Am J Physiol Cell Physiol 2009 297 1249 1262 10.1152/ajpcell.00188.2009 19726745
30. Estrogen is a modulator of vascular inflammation. Chakrabarti S, Lekontseva O, Davidge ST, IUBMB Life 2008 60 376 382 10.1002/iub.48 18409173
31. The action of hormonal steroids on the hypothalamo-pituitary-ovarian axis. Pincus G, Arch Anat Microsc Morphol Exp 1967 56 475 485 5615175
32. The effects of a long-acting progestin on the hypothalamic-pituitary- ovarian axis in women with normal menstrual cycles. Poindexter AN, Dildy GA, Brody SA, Snabes MC, Brodyand SA, Contraception 1993 48 37 45 10.1016/0010-7824(93)90064-E 8403904 (Pubitemid 23214349)
33. Salivary testosterone, cortisol, and progesterone: two-week stability, interhormone correlations, and effects of time of day, menstrual cycle, and oral contraceptive use on steroid hormone levels. Liening SH, Stanton SJ, Saini EK, Schultheiss OC, Physiol Behav 99 8 16
34. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins. Wiegratz I, Kutschera E, Lee JH, Moore C, Mellinger U, Winkler UH, Kuhl H, Contraception 2003 67 25 32 10.1016/S0010-7824(02)00436-5 12521654 (Pubitemid 36084284)
35. Influence of contraceptives on gamma glutamyltransferase activity. Straus B, Calic-runje R, Cepelak I, Acta Pharm Jugosl 1982 32 191 195 12312052 (Pubitemid 13202647)
36. Increased tumor necrosis factor-alpha in whole blood during the luteal phase of ovulatory cycles. Amory JH, Lawler R, Hitti J, J Reprod Med 2004 49 678 682 15457859 (Pubitemid 39128782)
37. Oral contraceptive use induces upregulation of the CCR5 chemokine receptor on CD4(+) T cells in the cervical epithelium of healthy women. Prakash M, Kapembwa MS, Gotch F, Patterson S, J Reprod Immunol 2002 54 117 131 10.1016/S0165-0378(01)00125-5 11839399 (Pubitemid 34143096)
38. Cultured human luteal peripheral monocytes secrete increased levels of interleukin-1. Polan ML, Kuo A, Loukides J, Bottomly K, J Clin Endocrinol Metab 1990 70 480 484 10.1210/jcem-70-2-480 2298860
39. Increased plasma interleukin-1 activity in women after ovulation. Cannon JG, Dinarello CA, Science 1985 227 1247 1249 10.1126/science.3871966 3871966 (Pubitemid 15142016)
40. Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells. Pacifici R, Carano A, Santoro SA, Rifas L, Jeffrey JJ, Malone JD, McCracken R, Avioli LV, J Clin Invest 1991 87 221 228 10.1172/JCI114975 1845868
41. The immune response during the luteal phase of the ovarian cycle: increasing sensitivity of human monocytes to endotoxin. Bouman A, Moes H, Heineman MJ, de Leij LF, Faas MM, Fertil Steril 2001 76 555 559 10.1016/S0015-0282(01)01971-9 11532481
42. Diet and the epigenetic (re)programming of phenotypic differences in behavior. McGowan PO, Meaney MJ, Szyf M, Brain Res 2008 1237 12 24 18694740
43. DNA methylation, smooth muscle cells, and atherogenesis. Hiltunen MO, Yla-Herttuala S, Arterioscler Thromb Vasc Biol 2003 23 1750 1753 10.1161/01.ATV.0000092871.30563.41 12947012 (Pubitemid 37254858)
44. The inheritance of epigenetic defects. Holliday R, Science 1987 238 163 170 10.1126/science.3310230 3310230 (Pubitemid 17139717)
45. Serum folate and Vitamin B12 levels in women using modern oral contraceptives (OC) containing 20 microg ethinyl estradiol. Sutterlin MW, Bussen SS, Rieger L, Dietl J, Steck T, Eur J Obstet Gynecol Reprod Biol 2003 107 57 61 10.1016/S0301-2115(02)00371-8 12593896 (Pubitemid 36194757)
46. N-methyl-D-glucamine improves the laser-induced fluorescence capillary electrophoresis performance in the total plasma thiols measurement. Zinellu A, Carru C, Galistu F, Usai MF, Pes GM, Baggio G, Federici G, Deiana L, Electrophoresis 2003 24 2796 2804 10.1002/elps.200305570 12929176 (Pubitemid 38089072)
47. Taurine determination by capillary electrophoresis with laser-induced fluorescence detection: from clinical field to quality food applications. Zinellu A, Sotgia S, Scanu B, Chessa R, Gaspa L, Franconi F, Deiana L, Carru C, Amino Acids 2009 36 35 41 10.1007/s00726-007-0022-5 18193477
48. High-throughput CZE-UV determination of arginine and dimethylated arginines in human plasma. Zinellu A, Sotgia S, Zinellu E, Pinna A, Carta F, Gaspa L, Deiana L, Carru C, Electrophoresis 2007 28 1942 1948 10.1002/elps.200600534 17486658 (Pubitemid 47040398)
49. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Esterbauer H, Cheeseman KH, Methods Enzymol 1990 186 407 421 2233308 (Pubitemid 20279982)
50. Rapid quantification of total genomic DNA methylation degree by short-end injection capillary zone electrophoresis. Sotgia S, Carru C, Franconi F, Fiori PB, Manca S, Pettinato S, Magliona S, Ginanneschi R, Deiana L, Zinellu A, J Chromatogr A 2008 1185 145 150 10.1016/j.chroma.2008.01.032 18255082
51. Macrophage stimulating protein (MSP) evokes superoxide anion production by human macrophages of different origin. Brunelleschi S, Penengo L, Lavagno L, Santoro C, Colangelo D, Viano I, Gaudino G, Br J Pharmacol 2001 134 1285 1295 10.1038/sj.bjp.0704356 11704649 (Pubitemid 33097259)
52. Toll-like receptors in innate immunity. Takeda K, Akira S, Int Immunol 2005 17 1 14 15585605